- Home
- AQB vs AVGR Comparison
AQB vs AVGR Comparison
Compare AQB & AVGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQB
- AVGR
- Stock Information
- Founded
- AQB 1991
- AVGR 2007
- Country
- AQB United States
- AVGR United States
- Employees
- AQB N/A
- AVGR N/A
- Industry
- AQB
- AVGR Medical/Dental Instruments
- Sector
- AQB
- AVGR Health Care
- Exchange
- AQB Nasdaq
- AVGR Nasdaq
- Market Cap
- AQB 3.0M
- AVGR 2.6M
- IPO Year
- AQB N/A
- AVGR 2015
- Fundamental
- Price
- AQB $0.75
- AVGR $0.56
- Analyst Decision
- AQB Hold
- AVGR Strong Buy
- Analyst Count
- AQB 2
- AVGR 1
- Target Price
- AQB N/A
- AVGR $5.00
- AVG Volume (30 Days)
- AQB 221.1K
- AVGR 877.5K
- Earning Date
- AQB 11-05-2024
- AVGR 03-19-2025
- Dividend Yield
- AQB N/A
- AVGR N/A
- EPS Growth
- AQB N/A
- AVGR N/A
- EPS
- AQB N/A
- AVGR N/A
- Revenue
- AQB $1,258,512.00
- AVGR $7,262,000.00
- Revenue This Year
- AQB N/A
- AVGR N/A
- Revenue Next Year
- AQB $43.65
- AVGR $93.49
- P/E Ratio
- AQB N/A
- AVGR N/A
- Revenue Growth
- AQB N/A
- AVGR N/A
- 52 Week Low
- AQB $0.47
- AVGR $0.39
- 52 Week High
- AQB $2.79
- AVGR $5.45
- Technical
- Relative Strength Index (RSI)
- AQB 50.10
- AVGR 43.82
- Support Level
- AQB $0.68
- AVGR $0.50
- Resistance Level
- AQB $0.98
- AVGR $0.65
- Average True Range (ATR)
- AQB 0.09
- AVGR 0.06
- MACD
- AQB -0.00
- AVGR 0.00
- Stochastic Oscillator
- AQB 33.93
- AVGR 32.90
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.
About AVGR Avinger Inc.
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.